SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-026454
Filing Date
2021-02-03
Accepted
2021-02-03 07:52:31
Documents
13
Period of Report
2021-02-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d124759d8k.htm   iXBRL 8-K 40316
2 EX-99.1 d124759dex991.htm EX-99.1 36342
  Complete submission text file 0001193125-21-026454.txt   220869

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA jazz-20210203.xsd EX-101.SCH 3074
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE jazz-20210203_lab.xml EX-101.LAB 18838
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jazz-20210203_pre.xml EX-101.PRE 11841
6 EXTRACTED XBRL INSTANCE DOCUMENT d124759d8k_htm.xml XML 3534
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33500 | Film No.: 21584219
SIC: 2834 Pharmaceutical Preparations